Differentially Expressed Genes in Pancreatic Ductal Adenocarcinomas Identified through Serial Analysis of Gene Expression

Cancer Biology and Therapy

Volumn 3, Issue 12, 2004, Pages 1254-1261

  Hustinx, Steven R ^a,c   Cao, Dengfeng ^a   Maitra, Anirban ^a,b   Sato, Norihiro ^a   Martin, Sean T ^a   Sudhir, D ^d   Iacobuzio Donahue, Christine ^a   Cameron, John L ^a   Yeo, Charles J ^a   Kern, Scott E ^a   Goggins, Michael ^a   Mollenhauer, Jan ^e   Pandey, Akhilesh ^b   Hruban, Ralph H ^a,f  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d Institute of Bioinformatics   (India)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Gene expression; Pancreatic cancer; SAGE

Indexed keywords

CD74 ANTIGEN; CXCL2 CHEMOKINE; CYCLIN E BINDING PROTEIN 1; DELETED IN MALIGNANT BRAIN TUMOR 1 PROTEIN; KALLIKREIN 6; MACROPHAGE INHIBITORY CYTOKINE 1; NEUGRIN PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG; COMPLEMENTARY DNA; TUMOR ANTIGEN;

ARTICLE; CELL CYCLE; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTROLLED STUDY; DATA BASE; ENZYME ACTIVITY; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE LIBRARY; GENE MAPPING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERIAL ANALYSIS OF GENE EXPRESSION; SIGNAL TRANSDUCTION; TISSUE; TISSUE MICROARRAY; VALIDATION PROCESS; ADENOCARCINOMA; CELL CULTURE; EXPRESSED SEQUENCE TAG; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; ONLINE SYSTEM; PANCREAS CARCINOMA; PANCREAS TUMOR;

ADENOCARCINOMA; ANTIGENS, NEOPLASM; CARCINOMA, PANCREATIC DUCTAL; DNA, COMPLEMENTARY; EXPRESSED SEQUENCE TAGS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ONLINE SYSTEMS; PANCREATIC NEOPLASMS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 17844408229     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.3.12.1238     Document Type: Article

References (54)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000; 50:7-33.
2. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001; 51:15-36.
3. Yeo CJ, Cameron JL. Prognostic factors in ductal pancreatic cancer. Langenbecks Arch Surg 1998; 383:129-33.
4. American Cancer Society Cancer Facts & Figures 2003. 1-48, 2003.
5. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37:S4-66.
6. Ryu B, Jones JB, Blades NJ, Parmigiani G, Hollingsworth MA, Hruban RH, et al. Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression. Cancer Res 2002; 62:819-26.
7. Argani P, Rosty C, Reiter RE, Wilentz RE, Murugesan SD, Leach SD, et al. Discovery of new markers of cancer through serial analysis of gene expression: Prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res 2001; 61:4320-4.
8. Iacobuzio-Donahue CA, Maitra A, Shen-Ong GL, van Heek T, Ashfaq R, Meyer R, et al. Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am J Pathol 2002; 160:1239-49.
9. Iacobuzio-Donahue CA, Ashfaq R, Maitra A, Adsay NV, Shen-Ong GL, Berg K, et al. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res 2003; 63:8614-22.
10. Han H, Bearss DJ, Browne LW, Calaluce R, Nagle RB, and Von Hoff DD. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res 2002; 62:2890-6.
11. Tan ZJ, Hu XG, Cao GS, and Tang Y. Analysis of gene expression profile of pancreatic carcinoma using cDNA microarray. World J Gastroenterol 2003; 9:818-23.
12. Argani P, Iacobuzio-Donahue CA, Ryu B, Rosty C, Goggins M, Wilentz RE, et al. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res 2001; 7:3862-8.
13. McCarthy DM, Maitra A, Argani P, Rader AE, Faigel DO, van Heek NT, et al. Novel markers of pancreatic adenocarcinoma in fine-needle aspiration: mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases. Appl Immunohistochem Mol Morphol 2003; 11:238-43.
14. Koopmann J, Fedarko NS, Jain A, Maitra A, Iacobuzio-Donahue C, Rahman A, et al. Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2004; 13:487-91.
15. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. Serial analysis of gene expression. Science 1995; 270:484-7.
16. Maitra A, Adsay NV, Argani P, Iacobuzio-Donahue C, De Marzo A, Cameron JL, et al. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod Pathol 2003; 16:902-12.
17. Liu N, Furukawa T, Kobari M, Tsao MS. Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma. Am J Pathol 1998; 153:263-9.
18. Furukawa T, Duguid WP, Rosenberg L, Viallet J, Galloway DA, and Tsao MS. Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. Am J Pathol 1996; 148:1763-70.
19. Livak KJ and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 2001; 25:402-8.
20. Mollenhauer J, Wiemann S, Scheurlen W, Korn B, Hayashi Y, Wilgenbus KK, et al. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nat Genet 1997; 17:32-9.
21. Koopmann J, Buckhaults P, Brown DA, Zahurak ML, Sato N, Fukushima N, et al. Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers. Clin Cancer Res 2004; 10:2386-92.
22. Petraki CD, Karavana VN, Revelos KI, Luo LY, Diamandis EP. Immunohistochemical localization of human kallikreins 6 and 10 in pancreatic islets. Histochem J 2002; 34:313-22.
23. Kang W, Reid KB. DMBT1, a regulator of mucosal homeostasis through the linking of mucosal defense and regeneration? FEBS Lett 2003; 540:21-5.
24. Ishigaki S, Niwa J, Yoshihara T, Mitsuma N, Doyu M, Sobue G. Two novel genes, human neugrin and mouse m-neugrin, are upregulated with neuronal differentiation in neuroblastoma cells. Biochem Biophys Res Commun 2000; 279:526-33.
25. Ceman S, Sant AJ. The function of invariant chain in class II-restricted antigen presentation. Semin Immunol 1995; 7:373-87.
26. Glabinski AR, Bielecki B, Ransohoff RM. Chemokine upregulation follows cytokine expression in chronic relapsing experimental autoimmune encephalomyelitis. Scand J Immunol 2003; 58:81-8.
27. Mitsui K, Nakanishi M, Ohtsuka S, Norwood TH, Okabayashi K, Miyamoto C, et al. A novel human gene encoding HECT domain and RCC1-like repeats interacts with cyclins and is potentially regulated by the tumor suppressor proteins. Biochem Biophys Res Commun 1999; 266:115-22.
28. Diamandis EP, Yousef GM. Human tissue kallikreins: a family of new cancer biomarkers. Clin Chem 2002; 48:1198-205.
29. Karan D, Chen SJ, Johansson SL, Singh AP, Paralkar VM, Lin MF, et al. Dysregulated expression of MIC-1/PDF in human prostate tumor cells. Biochem Biophys Res Commun 2003; 305:598-604.
30. Karan D, Kelly DL, Rizzino A, Lin MF, Batra SK. Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells. Carcinogenesis 2002; 23:967-75.
31. Buckhaults P, Rago C, St Croix B, Romans KE, Saha S, Zhang L, et al. Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res 2001; 61:6996-7001.
32. Brown DA, Ward RL, Buckhaults P, Liu T, Romans KE, Hawkins NJ, et al. MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clin Cancer Res 2003; 9:2642-50.
33. Takito J, Yan L, Ma J, Hikita C, Vijayakumar S, Warburton D, et al. Hensin, the polarity reversal protein, is encoded by DMBT1, a gene frequently deleted in malignant gliomas. Am J Physiol 1999; 277:F277-89.
34. Wu W, Kemp BL, Proctor ML, Gazdar AF, Minna JD, Hong WK, et al. Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer. Cancer Res 1999; 59:1846-51.
35. Mori M, Shiraishi T, Tanaka S, Yamagata M, Mafune K, Tanaka Y, et al. Lack of DMBT1 expression in oesophageal, gastric and colon cancers. Br J Cancer 1999; 79:211-3.
36. Sasaki M, Huang SF, Chen MF, Jan YY, Yeh TS, Ishikawa A, et al. Decrease of deleted in malignant brain tumour-1 (DMBT-1) expression is a crucial late event in intrahepatic cholangiocarcinoma. Histopathology 2003; 43:340-6.
37. Mollenhauer J, Helmke B, Medina D, Bergmann G, Gassler N, Muller H, et al. Carcinogen inducibility in vivo and down-regulation of DMBT1 during breast carcinogenesis. Genes Chromosomes Cancer 2004; 39:185-94.
38. Mollenhauer J, Herbertz S, Holmskov U, Tolnay M, Krebs I, Merlo A, et al. DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer. Cancer Res 2000; 60:1704-10.
39. Sasaki K, Sato K, Akiyama Y, Yanagihara K, Oka M, Yamaguchi K. Peptidomics-based approach reveals the secretion of the 29-residue COOH-terminal fragment of the putative tumor suppressor protein DMBT1 from pancreatic adenocarcinoma cell lines. Cancer Res 2002; 62:4894-8.
40. Gronborg M, Bunkenborg J, Kristiansen TZ, Jensen ON, Yeo CJ, Hruban RH, et al. A Comprehensive Proteomic Analysis of Human Pancreatic Juice. J Proteome Res 2004; In press.
41. Ishigami S, Natsugoe S, Tokuda K, Nakajo A, Iwashige H, Aridome K, et al. Invariant chain expression in gastric cancer. Cancer Lett 2001; 168:87-91.
42. Jiang Z, Xu M, Savas L, LeClair P, Banner BF. Invariant chain expression in colon neoplasms. Virchows Arch 1999; 435:32-6.
43. Weeraratna AT, Becker D, Carr KM, Duray PH, Rosenblatt KP, Yang S, et al. Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome. Oncogene 2004; 23:2264-74.
44. Young AN, Amin MB, Moreno CS, Lim SD, Cohen C, Petros JA, et al. Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am J Pathol 2001; 158:1639-51.
45. Datta MW, Shahsafaei A, Nadler LM, Freeman GJ, Dorfman DM. Expression of MHC class II-associated invariant chain (Ii;CD74) in thymic epithelial neoplasms. Appl Immunohistochem Mol Morphol 2000; 8:210-5.
46. Qiu G, Goodchild J, Humphreys RE, Xu M. Cancer immunotherapy by antisense suppression of Ii protein in MHC-class-II-positive tumor cells. Cancer Immunol Immunother 1999; 48:499-506.
47. Michel RB, Brechbiel MW, Mattes MJ. A comparison of 4 radionuclides conjugated to antibodies for single-cell kill. J Nucl Med 2003; 44:632-40.
48. Ong GL, Elsamra SE, Goldenberg DM, Mattes MJ. Single-cell cytotoxicity with radiolabeled antibodies. Clin Cancer Res 2001; 7:192-201.
49. Belperio JA, Keane MP, Burdick MD, Londhe V, Xue YY, Li K, et al. Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J Clin Invest 2002; 110:1703-16.
50. Sue RD, Belperio JA, Burdick MD, Murray LA, Xue YY, Dy MC, et al. CXCR2 is critical to hyperoxia-induced lung injury. J Immunol 2004; 172:3860-8.
51. Sato N, Fukushima N, Maitra A, Iacobuzio-Donahue CA, van Heek NT, Cameron JL, et al. Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. Am J Pathol 2004; 164:903-14.
52. Yousef GM, Polymeris ME, Yacoub GM, Scorilas A, Soosaipillai A, Popalis C, et al. Parallel overexpression of seven kallikrein genes in ovarian cancer. Cancer Res 2003; 63:2223-7.
53. Diamandis EP, Yousef GM, Soosaipillai AR, Bunting P. Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma. Clin Biochem 2000; 33:579-83.
54. Yousef GM, Borgono CA, Popalis C, Yacoub GM, Polymeris ME, Soosaipillai A, et al. Insilico analysis of kallikrein gene expression in pancreatic and colon cancers. Anticancer Res 2004; 24:43-51.